RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

The RAPS store will be under maintenance Saturday, 13 June between 6 AM and 12 PM EST. Store functionality may be unavailable at times during this window.
We apologize for any inconvenience caused during this time.

Regulatory Focus™ > News Articles > FDA Authorizes Use of New, Substantially Faster Ebola Diagnostic Tests

FDA Authorizes Use of New, Substantially Faster Ebola Diagnostic Tests

Posted 27 October 2014 | By Alexander Gaffney, RAC

FDA Authorizes Use of New, Substantially Faster Ebola Diagnostic Tests

The US Food and Drug Administration (FDA) has granted emergency use authorizations (EUAs) to two new diagnostic tests meant to help health professionals to accurately diagnose the Ebola Zaire virus in record time.

Background

In March 2013, FDA was given